![AHFS Drug Information logo.](https://www.pharmaceuticalpress.com/wp-content/themes/pharma-press/img/icons/icon-ahfs-drug-information.png)
9th July 2024
AHFS Drug Information
This update contains 10 new monographs and 95 revised monographs….
Psychotropic Drug Directory supports the optimal and rational use of medicines, to improve the quality of life for people with mental health needs.
Close
Close
Contact our team to see how our services can directly help you.
Close
Access our useful resources today to help your organisation realise the benefits of subscribing to Psychotropic Drug Directory through MedicinesComplete. Including patient case studies covering everyday clinical scenarios, and an on-demand webinar showing how to navigate independent information, advice, and commentary on psychotropic drugs.
Close
Register for this webinar to learn how Extended Stability for Parenteral Drugs supports confident decision making at the point of need.
Close
Read new content on medication errors.
Close
Published by the American Society of Health-System Pharmacists (ASHP), AHFS Drug Information is a dependable, comprehensive, and objective database for drug products approved by the FDA.
The American Hospital Formulary Service (AHFS) drug information database is maintained and updated continuously throughout the year.
The inclusion of evidence-based data on licensed and unlicensed drug use makes this a valuable reference for health professionals seeking to provide their patients with safe and effective therapy.
Our knowledge products are regularly updated online through MedicinesComplete
9th July 2024
This update contains 10 new monographs and 95 revised monographs….
9th July 2024
This update contains 10 new monographs and 95 revised monographs.
New monographs:
Aprocitentan; Capsaicin; Danicopan; Fidanacogene Elaparvovec-dzkt; Givinostat Hydrochloride; LetibotulinumtoxinA-wlbg; Nogapendekin Alfa Inbakicept-pmln; Sotatercept-csrk; Tovorafenib; Vadadustat.
Revised monographs:
Alteplase; Amiodarone Hydrochloride; Argatroban; Atenolol; azaTHIOprine, azaTHIOprine Sodium; Baclofen; Bethanechol Chloride; Bosutinib; Bumetanide; Bupivacaine Hydrochloride, Bupivacaine Liposomal; Cabozantinib S-malate; Canakinumab; Chloroprocaine Hydrochloride (Systemic); Chloroquine Phosphate; Cisatracurium Besylate; cloNIDine, cloNIDine Hydrochloride; Dexmedetomidine Hydrochloride ; dilTIAZem Hydrochloride; DOBUTamine Hydrochloride; Dopamine Hydrochloride; Dutasteride; Emtricitabine; Enasidenib Mesylate; EPINEPHrine, racEPINEPHrine; Esmolol Hydrochloride; Flecainide Acetate; Flucytosine; Glasdegib Maleate; Glatiramer Acetate; Heparin Sodium; hydrALAZINE Hydrochloride; hydroCHLOROthiazide; Hydrocortisone, Hydrocortisone Sodium Succinate; HYDROmorphone Hydrochloride; Hydroxyurea; Ibrexafungerp Citrate; Interferon Beta; Isoproterenol Hydrochloride; Ivosidenib; Labetalol Hydrochloride; Lanadelumab-flyo; Lansoprazole; Lidocaine Hydrochloride (Systemic); Lonapegsomatropin-tcgd; LORazepam; Lumacaftor and Ivacaftor; Magnesium Sulfate; Mercaptopurine; Methadone Hydrochloride; Metoprolol Succinate, Metoprolol Tartrate; metroNIDAZOLE, metroNIDAZOLE Hydrochloride; Midazolam, Midazolam Hydrochloride; Milrinone Lactate; Naloxone Hydrochloride; niCARdipine Hydrochloride; NIFEdipine; Niraparib Tosylate Monohydrate and Abiraterone Acetate; Nitroglycerin (Systemic); Ocrelizumab; Octreotide Acetate; Ofatumumab; Oxytocin; Palovarotene; Pantoprazole Sodium; PENTobarbital Sodium; Phenylephrine Hydrochloride (Systemic); Pimavanserin Tartrate; Pirfenidone; Pomalidomide; Ponesimod; Propofol; Pyrazinamide; Remifentanil Hydrochloride; rifAMPin; Rocuronium Bromide; Ropivacaine Hydrochloride; Semaglutide; Sodium Chloride; Sodium Nitroprusside; Somatrogon-ghla; Spironolactone; Tacrolimus (Atopic Dermatitis); Tacrolimus (Immunomodulatory Agent); Talquetamab-tgvs; Terbutaline Sulfate; Thioguanine; Topiramate; Tranexamic Acid; Trifluridine and Tipiracil Hydrochloride; Upadacitinib; Ursodiol; valACYclovir Hydrochloride; Vasopressin; Vecuronium Bromide; Zidovudine.
11th June 2024
This update contains 6 new monographs and 44 revised monographs….
11th June 2024
This update contains 6 new monographs and 44 revised monographs.
New monographs: Atidarsagene Autotemcel; Iloprost (Frostbite); Macitentan and Tadalafil; Pemivibart; Resmetirom; Tislelizumab-jsgr.
Revised monographs: Abatacept; Alemtuzumab (Antineoplastic); Alemtuzumab (Multiple Sclerosis); Alprostadil; Amantadine Hydrochloride (Antiparkinson); Amantadine Hydrochloride (Antiviral); Amiodarone Hydrochloride; Apalutamide; Asciminib Hydrochloride; Binimetinib; Cantharidin; Cisatracurium Besylate; Coagulation Factor IX (recombinant), GlycoPEGylated; Copanlisib Hydrochloride; Dalfampridine; Darolutamide; Darunavir; Dimethyl Fumarate; Diroximel Fumarate; Dostarlimab-gxly; Efgartigimod Alfa; Eflapegrastim-xnst; Emicizumab-kxwh; Erenumab-aooe; Everolimus; fentaNYL, fentaNYL Citrate; Finasteride (BPH); Finasteride (Hair Growth); Fremanezumab-vfrm; Galcanezumab-gnlm; Iloprost; Lopinavir and Ritonavir; Luspatercept-aamt; Nirmatrelvir and Ritonavir; Olaparib; Omaveloxolone; Pegcetacoplan (Geographic Atrophy); Rucaparib Camsylate; Selumetinib Sulfate; Sodium Oxybate; Somatropin; Teplizumab-mzwv; Tretinoin; Ublituximab-xiiy.
14th May 2024
This update contains 5 new monographs and 26 revised monographs….
14th May 2024
This update contains 5 new monographs and 26 revised monographs.
New monographs: Berdazimer Sodium; Birch Triterpenes; Brincidofovir; Cefepime Hydrochloride and Enmetazobactam; Lifileucel.
Revised monographs: Abrocitinib; Acalabrutinib; Alpelisib; Amisulpride; Brigatinib; Cabotegravir and Rilpivirine; Cabotegravir Sodium; COVID-19 Vaccine, Adjuvanted (Novavax); COVID-19 Vaccine, mRNA (Moderna); COVID-19 Vaccine, mRNA (Pfizer-BioNTech); Daprodustat; Dasatinib; Dolutegravir Sodium; Faricimab-svoa; Givosiran Sodium; lamiVUDine; Letermovir; Maribavir; Monomethyl Fumarate; Mosunetuzumab-axgb; Odevixibat; Pirtobrutinib; Sarilumab; Tenofovir Alafenamide Fumarate; Valbenazine Tosylate; Vericiguat.
9th April 2024
This update contains 4 new monographs and 33 revised monographs….
9th April 2024
This update contains 4 new monographs and 33 revised monographs.
New monographs: Eflornithine Hydrochloride; Sildenafil Citrate (Pulmonary Hypertension); Tadalafil (Pulmonary Hypertension); Taurolidine and Heparin Sodium.
Revised monographs: Abacavir Sulfate; Adagrasib; Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl; Avapritinib; Belimumab; Belzutifan; Cobimetinib Fumarate; Dexmedetomidine Hydrochloride; Dolutegravir Sodium and Lamivudine; Dolutegravir Sodium and Rilpivirine Hydrochloride; Dupilumab; Elexacaftor, Tezacaftor, and Ivacaftor; Fremanezumab-vfrm; Ibalizumab-uiyk; Ivacaftor; Rozanolixizumab-noli; Semaglutide; Sildenafil Citrate (Erectile Dysfunction); Sotorasib; Sparsentan; Tadalafil (Erectile Dysfunction, Benign Prostatic Hyperplasia); Tazemetostat Hydrobromide; Tenofovir Disoproxil Fumarate; Tepotinib Hydrochloride; Tesamorelin Acetate; Tezacaftor and Ivacaftor; Tralokinumab-ldrm; Ubrogepant; Vandetanib; Vismodegib; Vosoritide; Voxelotor ; Zavegepant Hydrochloride.
12th March 2024
This update contains 5 new monographs, 28 revised monographs, 10…
12th March 2024
This update contains 5 new monographs, 28 revised monographs, 10 discontinued monographs and 2 new MedWatch alerts.
New monographs: Chikungunya Vaccine Live; Eplontersen Sodium; Exagamglogene Autotemcel; Lovotibeglogene autotemcel; Sotagliflozin.
Revised monographs: Aducanumab; Atogepant; Belumosudil Mesylate; Crizotinib; Deferasirox; Denosumab; Difelikefalin Acetate; Elacestrant Hydrochloride; Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate; Emapalumab; Etravirine; Filgrastim; Fostamatinib Disodium Hexahydrate; inFLIXimab; Lecanemab; Maralixibat Chloride; Mavacamten; Nivolumab and Relatlimab; Norepinephrine Bitartate; Raltegravir Potassium; Ravulizumab; Relugolix, Estradiol, and Norethindrone Acetate; Retifanlimab; Setmelanotide Acetate; Sirolimus (Immunosuppressive Agent); Temsirolimus; Trofinetide; Vonoprazan.
Discontinued monographs: Abciximab; Anti-infectives Available from CDC; COVID-19 Vaccine (Janssen); Eflornithine; HYDROXYprogesterone; Immunization Schedules; Immunobiologic Agents Available from CDC; Measles, Mumps, and Rubella Vaccine; Mobocertinib; Vonoprazan, Clarithromycin, and Amoxicillin.
New MedWatch alerts on the following monographs: Semaglutide; Sotagliflozin.
13th February 2024
This update contains 11 new monographs, 24 revised monographs, and…
13th February 2024
This update contains 11 new monographs, 24 revised monographs, and 9 new MedWatch alerts.
New monographs: ADAMTS13, Recombinant-krhn; Capivasertib; Efbemalenograstim Alfa-vuxw; Fruquintinib; Ipratropium Bromide (EENT); Iptacopan Hydrochloride; levOCARNitine; Meningococcal Groups A, B, C, W, and Y Vaccine; Nirogacestat Hydrobromide; Repotrectinib; Zilucoplan Sodium.
Revised monographs: Alpelisib; Amifampridine Phosphate; Ansuvimab-zykl; Atazanavir Sulfate; Atoltivimab, Maftivimab, and Odesivimab-ebgn; Avalglucosidase Alfa-ngpt; Axitinib; Bictegravir Sodium, Emtricitabine, and Tenofovir Alafenamide Fumarate; Cladribine (Immunomodulatory Agent); Denosumab; Doravirine; Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide Fumarate; Entecavir; Fosdenopterin Hydrobromide; Futibatinib; Lenalidomide; Lumasiran Sodium; Ocrelizumab; Pasireotide; Pegcetacoplan; Siponimod Fumarate; Teprotumumab-trbw; Tezepelumab-ekko; Vibegron.
New MedWatch alerts on the following monographs: Axicabtagene Ciloleucel; Brexucabtagene Autoleucel; Ciltacabtagene Autoleucel; cloBAZam; Eflornithine; Idecabtagene Vicleucel; LevETIRAcetam; Lisocabtagene Maraleucel; Tisagenlecleucel.
Access AHFS Drug Information through MedicinesComplete today.
Contact us now for pricing and access information.
$99.00
Info$110.00
Info$850.00
InfoSee all our printed publications in the Shop.